Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Cancer Causes Control. 2010 Jun;21(6):821-8. doi: 10.1007/s10552-010-9508-7. Epub 2010 Jan 19.
We used a nested case-control design within a large, multi-center cohort of women who underwent a biopsy for benign breast disease (BBD) to assess the association of broad histologic groupings and specific histologic entities with risk of breast cancer.
Cases were all women who had a biopsy for BBD and who subsequently developed breast cancer; controls were individually matched to cases and were women with a biopsy for BBD who did not develop breast cancer in the same follow-up interval as that for the cases. After exclusions, 1,239 records (615 cases and 624 controls) were available for analysis. We used conditional logistic regression to estimate odds ratios and 95% confidence intervals (CIs).
Relative to non-proliferative BBD/normal pathology, the multivariable-adjusted odds ratio for proliferative lesions without atypia was 1.45 (95% CI 1.10-1.90), and that for atypical hyperplasia was 5.27 (95% CI 2.29-12.15). The presence of multiple foci of columnar cell hyperplasia and of complex fibroadenoma without atypia was associated with a non-significantly increased risk of breast cancer, whereas sclerosing adenosis, radial scar, and papilloma showed no association with risk.
Our results indicate that, compared to women with normal pathology/non-proliferative disease, women with proliferative disease without atypia have a modestly increased risk of breast cancer, whereas women with atypical hyperplasia have a substantially increased risk.
我们使用嵌套病例对照设计,对接受良性乳腺疾病(BBD)活检的大型多中心女性队列进行研究,评估广泛的组织学分组和特定组织学实体与乳腺癌风险之间的关系。
病例均为因 BBD 行活检且随后发生乳腺癌的女性;对照与病例个体匹配,为因 BBD 行活检且在与病例相同的随访期内未发生乳腺癌的女性。排除后,有 1239 份记录(615 例病例和 624 例对照)可用于分析。我们使用条件逻辑回归估计比值比和 95%置信区间(CI)。
与非增殖性 BBD/正常病理学相比,无非典型性增生的增殖性病变的多变量调整比值比为 1.45(95%CI 1.10-1.90),而不典型性增生的比值比为 5.27(95%CI 2.29-12.15)。多个柱状细胞增生灶和无非典型性的复杂纤维腺瘤的存在与乳腺癌风险呈非显著增加相关,而硬化性腺病、放射状瘢痕和乳头瘤与风险无关联。
我们的结果表明,与具有正常病理学/非增殖性疾病的女性相比,无非典型性增生的增殖性疾病女性的乳腺癌风险略有增加,而不典型性增生的女性的乳腺癌风险显著增加。